LD/CD Infusion Improves & quot;ON & quot; Time, Outcomes in Parkinson ' s LD/CD Infusion Improves & quot;ON & quot; Time, Outcomes in Parkinson ' s

Offering levodopa/carbidopa as a 24-hour continuous subcutaneous infusion could help to improve treatment on times and motor experiences of daily living compared with oral preparations.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news